ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Class 4 Drug Caution in use - SLENYTO 1 MG AND 5MG PROLONGED RELEASE TABLETS

Recalls and Alerts

Class 4 Caution in Use

Class 4 Drug Caution in use - SLENYTO 1 MG AND 5MG PROLONGED RELEASE TABLETS

Flynn Pharma Ltd, distributors of Slenyto 1 mg and 5mg prolonged release tablets would like to notify you of an error with the patient information leaflets (PILs) that have been packaged in the below batches of products. These were an older version of the PIL which did not include the most up to date safety information

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-slenyto-1-mg-and-5mg-prolonged-release-tablets-distributed-by-flynn-pharma-ltd-el-21-a-slash-29?utm_medium=email&utm_campaign=govuk-notifications&utm_source=918a7eae-bd86-4833-899a-5114d92b0980&utm_content=immediately      

 

Pip code

Product description

Supplier

Batch Numbers

4102091

SLENYTO 1MG PROLONGED RELEASE TAB

FLYNN PHARMA LTD

1049309A

1049310

1049311

1049312

1051815

80419B

90287

10175A

10186

4102083

SLENYTO 5MG PROLONGED RELEASE TAB

FLYNN PHARMA LTD

00130

00409C

10058

 

 

Alliance healthcare do not stock this product therefore we are not accepting stock returns.

 

Further Information

 

For more information, medical information queries or replacement PIL enquiries, please contact:

 

Flynn Pharma Ltd Medical Information Department on 01438 727822, email – medinfo@flynnpharma.com.

 

For stock control queries, please contact: Flynn Pharma Ltd on 01438 727822

 

If you have any questions, then please contact your local Service Centre Customer Services team.